| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.29 | 3e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |